May 16, 2018 / 8:12 PM / 2 months ago

BRIEF-Cimzia Is The First Therapy To Demonstrate Positive Results In A 52-Week, Placebo Controlled Non-Radiographic Axial Spondyloarthritis Study

May 16 (Reuters) - Ucb SA:

* CIMZIA® (CERTOLIZUMAB PEGOL) IS THE FIRST THERAPY TO DEMONSTRATE POSITIVE RESULTS IN A 52-WEEK, PLACEBO CONTROLLED NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STUDY

* UCB SA - STUDY MET PRIMARY OBJECTIVE AND ALSO MET A KEY SECONDARY OBJECTIVE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below